Peru declares national emergency amid rising cases of Guillain Barre Syndrome

ER Editor: See also this article by Dr. William Makis titled

Guillain-Barre Syndrome (GBS): Neurological Injury Caused by COVID-19 mRNA Vaccines

Of note:

Guillain-Barré syndrome (GBS) is a rare auto-immune disease that triggers the immune system of the body to attack its own nervous system, specifically the peripheral nerves responsible for sensation and motor control.

GBS causes the demyelination of Schwann cells, which causes damage to peripheral nerves and affects the way signals are sent. As a result, GBS can cause weakness, tingling, changes in sensations and paralysis in individuals affected.

The first symptoms reported are often a feeling of altered sensation in the feet and hands, and a feeling of weakness in lower legs. The feeling of weakness may also progress through the arms, legs, chest and face. In most cases, this weakness will progress to become paralysis of the muscles in these areas.

If significant weakness or paralysis occurs in the chest, individuals will experience respiratory issues. This may result in patients needing more care, mechanical ventilation and suctioning from their healthcare team. …

GBS is one of the more common neurological injuries caused by COVID-19 vaccines.

The article below only refers to GBS as being a result of so-called infectious conditions, not the Covid shots.

Front Nieuws also picked up the story from a different source (Peru declares public health emergency after outbreak of Guillain-Barre syndrome vaccine side effect). Of note:

The exact cause of Guillain-Barre syndrome is unknown, but it is officially listed as a side effect in people who have received the Johnson & Johnson or AstraZeneca COVID-19 vaccine. Both vaccines were widely administered in Peru, where 92% of the population is vaccinated.


Peru declares national emergency amid rising cases of Guillain Barre Syndrome, fears immunoglobulin shortage

Published in El Peruano, the official gazette of the Republic of Peru, the government termed the rise in Guillain-Barre Syndrome cases as unusual.


Peruvian Health Minister Cesar Vasquez sought the emergency declaration before the Council of Ministers noting that if the number of cases increases, then there could be a shortage of immunoglobulin (antibodies).

Published in El Peruano, the official gazette of the Republic of Peru, the government termed the rise in Guillain-Barre Syndrome cases as unusual. It said that until 23rd June, 103 cases of the syndrome were reported and the “average monthly number of cases was less than 20 cases per month at the national level (less than that reported in years prior to the 2019 outbreak).

However, between June 11 and 17, a slight increase in cases was reported compared to the average observed in previous weeks, in which between 2 and 8 cases were reported.

The departments that reported the highest number of cases during the year 2023 were Lima (26 cases), La Libertad (19), Cajamarca (11), Piura (9), Cusco (7), Junín (8), and Callao (5); and, of the 16 cases reported with a date of onset of muscle weakness in the SE 24 come from Piura (4), La Libertad (3), Lima (3), Cajamarca (2), Callao (2) and Junín (2).

“This week, deaths from said syndrome have also been reported,” the decree stated.

A rigorous campaign is now being conducted in Peru including epidemiological surveillance, investigation, supply of medicines, and patient care.

The action plan includes carrying out specialized diagnosis of the biological agents associated with GBS, acquisition of intravenous immunoglobulin (5%), acquisition of 20% human albumin x 50 ml, monitoring and coordination to improve the operational capacity of GBS care services, air transport of patients in emergency cases, case management by teleinterconsultation, and so on.

What is Guillain-Barre syndrome?

The nerve-attacking syndrome leads to weakness and tingling in the hands and feet in the initial symptoms. The symptoms can spread all over the body sometimes even paralyzing the patient in severe cases.

While most people must receive hospital treatment in this case, recovery is generally achieved anywhere between 6 months to some years in some cases.

GBS is often preceded by a virus infection. In Peru, there have been 4,512,091 cases of covid-19 from January 2020 to 5th July 2023. Notably, one of the post covid problems has been neurological or related to nerves. (ER: And the elephant in the room …)




The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

Be the first to comment

Leave a Reply

Your email address will not be published.